Page last updated: 2024-10-29

indomethacin and Placental Insufficiency

indomethacin has been researched along with Placental Insufficiency in 1 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Placental Insufficiency: Failure of the PLACENTA to deliver an adequate supply of nutrients and OXYGEN to the FETUS.

Research Excerpts

ExcerptRelevanceReference
"When indomethacin was used to inhibit prostaglandin synthesis, placental vascular resistance did not increase, placental blood flow did not decrease, and fetal blood gases remained at normal prebypass levels during and after fetal cardiac bypass."1.28Prostaglandin synthesis inhibition prevents placental dysfunction after fetal cardiac bypass. ( Assad, RS; Hanley, FL; Sabik, JF, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sabik, JF1
Assad, RS1
Hanley, FL1

Other Studies

1 other study available for indomethacin and Placental Insufficiency

ArticleYear
Prostaglandin synthesis inhibition prevents placental dysfunction after fetal cardiac bypass.
    The Journal of thoracic and cardiovascular surgery, 1992, Volume: 103, Issue:4

    Topics: Analysis of Variance; Animals; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Female; Fetus; I

1992